KFDA approves advanced clinical study of new atopic dermatitis medication

Published: 2009-12-16 06:56:00

Updated: 2009-12-16 06:56:00

Hanall Pharm said on December 14 that it has received approval from the Korea Food and Drug Administration to conduct a dose-finding Phase 2 study of a drug for the treatment of atopic dermatitis.

The company said the approval comes after successful completion of animal, pre-clinical experimen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK